Clinical Trial Update: A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia [Phase 3]

View source ↗

Summary

Phase 3 study comparing megestrol acetate 800 mg daily to placebo in AIDS patients with anorexia and cachexia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Anorexia
• Cachexia

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anorexia, Cachexia | Phase 3 | Status: COMPLETED